Edesa Biotech Inc reports results for the quarter ended in December - Earnings Summary

Edesa Biotech

13/02/2023 14:30

* Edesa Biotech Inc  EDSA.OQ  reported a quarterly adjusted
loss
of 13 cents​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of 19 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Edesa Biotech Inc's reported EPS for the quarter was a
loss
of 13 cents​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Edesa Biotech Inc shares had fallen by 33.3% this quarter.
    * The company reported a quarterly loss of $2.34 million.
    * Wall Street's median 12-month price target for Edesa
Biotech Inc
is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
13 at 02:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.19          -0.13          Beat
 Sep. 30 2022      -0.39          -0.02          Beat
 Jun. 30 2022      -0.43          -0.37          Beat
 Mar. 31 2022      -0.37          -0.33          Beat